38546-01-9

Basic information

• Product Name: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
• Synonyms: Rifamycin, 3-[[(1,3-dihydro-1-oxo-2H-isoindol-2-yl)imino]methyl]- (9CI)
• CAS NO: 38546-01-9
• Molecular Formula: C₄₆H₅₃N₃O₁₃
• Molecular Weight: 855.9253
• Mol File: 38546-01-9.mol
• Article Data: 1

Chemical Properties

• Density: 1.4g/cm³
• Refractive Index: 1.655
• CAS DataBase Reference: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(38546-01-9)
• EPA Substance Registry System: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(38546-01-9)

Safety Data

• Hazardous Substances Data: 38546-01-9(Hazardous Substances Data)

Usage

Description

(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is a complex organic compound characterized by its long chemical structure. It features multiple hydroxy, methoxy, and methyl groups, an acetate functional group, an amino group, and an epoxide moiety. (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate also includes a naphthofuran ring and an isoindole ring. The presence of these diverse functional groups and complex ring systems suggests potential bioactive properties, making it a compound of interest for medicinal or pharmaceutical research.

Uses

Used in Pharmaceutical Research:
(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a compound of interest for pharmaceutical research due to its complex structure and potential bioactive properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a starting material for the development of new drugs, given its unique structural features and the possibility of various interactions with biological targets.

Upstream product

• 23990-34-3 2-aminoisoindolin-1-one 
• 13292-22-3 3-formylrifamycin SV 

Relevant articles and documents

Hydrazones of 3 formylrifamycin SV. Part III. N(mono and di)substituted hydrazone derivatives: synthesis, antibacterial activity and other biological properties

-